Contract 75A50120F33009
Seqirus Inc · Department Of Health And Human Services · September 28, 2021
Seqirus Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 28, 2021 for $57,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Holly Springs, NC. This is a task or delivery order issued under parent IDIQ 75A50118D00004. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $171,000.
Contract details
- PIID
- 75A50120F33009
- Parent IDIQ
- 75A50118D00004
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Drugs And Biologicals
- Place of performance
- Holly Springs, NC
- First action
- September 28, 2021
Description
ADD FUNDING FOR FAR 52.217-8
Modification timeline
-
September 28, 2021Mod P00002 · Funding Only Action$171.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50120F33009?
Contract 75A50120F33009 is a federal contract awarded to Seqirus Inc by Department Of Health And Human Services on September 28, 2021 for $57,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75A50120F33009?
Seqirus Inc won contract 75A50120F33009 from Department Of Health And Human Services.
How much is contract 75A50120F33009 worth?
Contract 75A50120F33009 has obligated $57,000 to date, with a total potential value of $171,000 if all options are exercised.